PPNa-DBS for gait and balance disorders in Parkinson’s disease: a double-blind, randomised study

Journal of Neurology

Volumn 262, Issue 6, 2015, Pages 1515-1525

  Welter, Marie Laure ^a,b,c,d,e   Demain, Adele ^a,b,c,d,e   Ewenczyk, Claire ^a,b,c,d,e   Czernecki, Virginie ^e   Lau, Brian ^a,b,c,d   El Helou, Amine ^d   Belaid, Hayat ^e   Yelnik, Jérôme ^a,b,c,d   François, Chantal ^a,b,c,d   Bardinet, Eric ^a,b,c,d,f   Karachi, Carine ^a,b,c,d,e   Grabli, David ^a,b,c,d,e  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CNRS   (France)

^d INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f ICM   (France)

Author keywords

Deep brain stimulation; Gait disorders; Parkinson s disease; Pedunculopontine nucleus

Indexed keywords

LEVODOPA; ANTIPARASITIC AGENT;

AGED; ANGER; ARTICLE; ATTENTION; BALANCE DISORDER; BODY POSTURE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISABILITY; DISEASE DURATION; DISGUST; DOUBLE BLIND PROCEDURE; EXECUTIVE FUNCTION; FACIAL EXPRESSION; FALLING; FEAR; FEMALE; GAIT DISORDER; HAPPINESS; HUMAN; INFECTION; MALE; MEMORY; MENTAL DISEASE; NEUROPHYSIOLOGY; OUTCOME ASSESSMENT; PARKINSON DISEASE; PARKINSONISM; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PSYCHOLOGIC TEST; QUALITY OF LIFE; SADNESS; STROOP TEST; UNIFIED PARKINSON DISEASE RATING SCALE; VELOCITY; BODY EQUILIBRIUM; COMPLICATION; GAIT DISORDERS, NEUROLOGIC; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PROCEDURES; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SENSATION DISORDERS; THREE DIMENSIONAL IMAGING;

AGED; ANTIPARASITIC AGENTS; DEEP BRAIN STIMULATION; DOUBLE-BLIND METHOD; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; IMAGING, THREE-DIMENSIONAL; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; POSTURAL BALANCE; SENSATION DISORDERS; SURVEYS AND QUESTIONNAIRES;

EID: 84931004975     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-7744-1     Document Type: Article

References (45)

1. Kempster PA, O’Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of Parkinson’s disease: a clinico-pathological study. Brain 133:1755–1762
2. Kaltenboeck A, Johnson SJ, Davis MR et al (2012) Direct costs and survival of medicare beneficiaries with early and advanced Parkinson’s disease. Parkinsonism Relat Disord 18:321–326
3. Bonnet AM, Loria Y, Saint-Hilaire MH, Lhermitte F, Agid Y (1987) Does long-term aggravation of Parkinson’s disease result from nondopaminergic lesions? Neurology 37:1539–1542
4. Welter ML, Houeto JL, Tezenas du Montcel S et al (2002) Clinical predictive factors of subthalamic stimulation in Parkinson’s disease. Brain 125:575–583
5. Karachi C, Grabli D, Bernard FA et al (2010) Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest 120:2745–2754
6. Snijders AH, Leunissen I, Bakker M et al (2011) Gait-related cerebral alterations in patients with Parkinson’s disease with freezing of gait. Brain 134:59–72
7. Karachi C, Andre A, Bertasi E, Bardinet E, Lehericy S, Bernard FA (2012) Functional parcellation of the lateral mesencephalus. J Neurosci 32:9396–9401
8. Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F (1987) Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA 84:5976–5980
9. Pahapill PA, Lozano AM (2000) The pedunculopontine nucleus and Parkinson’s disease. Brain 123:1767–1783
10. Jahn K, Deutschlander A, Stephan T et al (2008) Imaging human supraspinal locomotor centers in brainstem and cerebellum. Neuroimage 39:786–792
11. Bohnen NI, Muller ML, Koeppe RA et al (2009) History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology 73:1670–1676
12. Bohnen NI, Frey KA, Studenski SA et al (2013) Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology 81:1611–1616
13. Plaha P, Gill SS (2005) Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson’s disease. NeuroReport 16:1883–1887
14. Stefani A, Lozano AM, Peppe A et al (2007) Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson’s disease. Brain 130:1596–1607
15. Khan S, Gill SS, Mooney L et al (2012) Combined pedunculopontine-subthalamic stimulation in Parkinson disease. Neurology 78:1090–1095
16. Ferraye MU, Debu B, Fraix V et al (2010) Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson’s disease. Brain 133:205–214
17. Moro E, Hamani C, Poon YY et al (2010) Unilateral pedunculopontine stimulation improves falls in Parkinson’s disease. Brain 133:215–224
18. Thevathasan W, Coyne TJ, Hyam JA et al (2011) Pedunculopontine nucleus stimulation improves gait freezing in Parkinson disease. Neurosurgery 69:1248–1253 (discussion 1254)
19. Thevathasan W, Cole MH, Graepel CL et al (2012) A spatiotemporal analysis of gait freezing and the impact of pedunculopontine nucleus stimulation. Brain 135:1446–1454
20. Giladi N, Horak FB, Hausdorff JM (2013) Classification of gait disturbances: distinguishing between continuous and episodic changes. Mov Disord 28:1469–1473
21. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442
22. Fahn S, Elton RL, Members of UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent Developments in Parkinson’s disease, vol 2. Macmillan, New Jersey, pp 153–163
23. Schmidt R, Freidl W, Fazekas F et al (1994) The Mattis Dementia Rating Scale: normative data from 1,001 healthy volunteers. Neurology 44:964–966
24. Zrinzo L, Zrinzo LV, Tisch S et al (2008) Stereotactic localization of the human pedunculopontine nucleus: atlas-based coordinates and validation of a magnetic resonance imaging protocol for direct localization. Brain 131:1588–1598
25. Bardinet E, Bhattacharjee M, Dormont D et al (2009) A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease. J Neurosurg 110:208–219
26. Martinez-Martin P, Garcia Urra D, del Ser Quijano T et al (1997) A new clinical tool for gait evaluation in Parkinson’s disease. Clin Neuropharmacol 20:183–194
27. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N (1997) The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing 26:353–357
28. Pillon B (2002) Neuropsychological assessment for management of patients with deep brain stimulation. Mov Disord 17(Suppl 3):S116–S122
29. Asberg M, Montgomery SA, Perris C, Schalling D, Sedvall G (1978) A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl 5–27
30. Ekman P, Friesen WV (1976) Pictures of facial affect. Consulting Psychologist Press, Palo Alto
31. Demain A, Westby GW, Fernandez-Vidal S et al (2014) High-level gait and balance disorders in the elderly: a midbrain disease? J Neurol 261:196–206
32. Chastan N, Do MC, Bonneville F et al (2009) Gait and balance disorders in Parkinson’s disease: impaired active braking of the fall of centre of gravity. Mov Disord 24:188–195
33. Weiss A, Brozgol M, Dorfman M et al (2013) Does the evaluation of gait quality during daily life provide insight into fall risk? A novel approach using 3-day accelerometer recordings. Neurorehabil Neural Repair 27:742–752
34. Frank JS, Horak FB, Nutt J (2000) Centrally initiated postural adjustments in parkinsonian patients on and off levodopa. J Neurophysiol 84:2440–2448
35. Hamani C, Moro E, Lozano AM (2011) The pedunculopontine nucleus as a target for deep brain stimulation. J Neural Transm 118:1461–1468
36. Ballanger B, Lozano AM, Moro E et al (2009) Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson’s disease: a [(15)O] H2O PET study. Hum Brain Mapp 30:3901–3909
37. Pierantozzi M, Palmieri MG, Galati S et al (2008) Pedunculopontine nucleus deep brain stimulation changes spinal cord excitability in Parkinson’s disease patients. J Neural Transm 115:731–735
38. Butson CR, Cooper SE, Henderson JM, McIntyre CC (2007) Patient-specific analysis of the volume of tissue activated during deep brain stimulation. Neuroimage 34:661–670
39. Takakusaki Habaguchi T, Ohtinata-Sugimoto J, Saitoh K, Sakamoto T (2003) Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction. Neuroscience 119:293–308
40. Grabli D, Karachi C, Folgoas E et al (2013) Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems. J Neurosci 33:11986–11993
41. Hutchison WD, Allan RJ, Opitz H et al (1998) Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson’s disease. Ann Neurol 44:622–628
42. Breit S, Lessmann L, Unterbrink D, Popa RC, Gasser T, Schulz JB (2006) Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model. Eur J Neurosci 24:2275–2282
43. Bergman H, Wichmann T, DeLong MR (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249:1436–1438
44. Hariz MI (2002) Complications of deep brain stimulation surgery. Mov Disord 17(Suppl 3):S162–S166
45. Welter ML, Schupbach M, Czernecki V et al (2014) Optimal target localization for subthalamic stimulation in patients with Parkinson disease. Neurology 82:1352–1361